Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clinical impact of circulating biomarkers in prediction of adverse cardiac events in patients with congenital heart disease. A systematic review.

International journal of cardiology·2024
Same author

Temporal evolution of anxiety and depression in chronic heart failure and its association with clinical outcome.

International journal of cardiology·2024
Same author

The plasma proteome is linked with left ventricular and left atrial function parameters in patients with chronic heart failure.

European heart journal. Cardiovascular Imaging·2024
Same author

Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial.

Journal of hypertension·2023
Same author

Prognostic value of temporal patterns of left atrial reservoir strain in patients with heart failure with reduced ejection fraction.

Clinical research in cardiology : official journal of the German Cardiac Society·2023
Same author

LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis.

Atherosclerosis·2023

相关实验视频

Updated: Jun 10, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

在非ST升高的急性冠状动脉综合征中抑制血小板糖蛋白IIb/IIIa受体:仅在医疗治疗期间获得早期益处,在穿皮冠状动脉干预期间提供额外的保护.

E Boersma1, K M Akkerhuis, P Théroux

  • 1Thoraxcenter, University Hospital Rotterdam, Netherlands. boersma@thch.azr.nl

Circulation
|November 16, 1999
PubMed
概括

糖蛋白IIb/IIIa抑制剂显著减少急性冠状动脉综合征患者的心脏事件,并保护皮肤冠状动脉干预 (PCI) 期间的并发症. 这些好处在早期和PCI程序期间是显而易见的.

更多相关视频

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
08:13

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization

Published on: December 3, 2020

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

相关实验视频

Last Updated: Jun 10, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
08:13

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization

Published on: December 3, 2020

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

科学领域:

  • 心脏病学 心脏病学
  • 药理学 药理学是指药理学的学科.
  • 血栓形成的原因之一是血栓形成.

背景情况:

  • 糖蛋白 (GP) IIb/IIIa受体阻塞剂对于在没有ST段升高的情况下治疗急性冠状动脉综合征 (ACS) 至关重要.
  • 它们还可以在皮肤冠状动脉干预 (PCI) 期间预防血栓并发症.
  • 这项研究调查了这两个好处是否独立和相辅相成.

研究的目的:

  • 评估GP IIb/IIIa抑制剂在ACS患者中的疗效.
  • 在PCI期间确定GP IIb/IIIa抑制剂的保护作用.
  • 评估医疗治疗和PCI期间的益处是否是附加的.

主要方法:

  • 分析了来自三个随机试验的数据:CAPTURE,PURSUIT和PRISM-PLUS.
  • 包括患有急性冠状动脉综合征而没有持续的ST段升高的患者.
  • 评估医疗治疗期间和PCI后的结果.

主要成果:

  • 在医疗治疗期间,GP IIb/IIIa抑制剂显示死亡或非致命心肌梗塞的相对减少34% (2.5%对3.8%).
  • 在接受GPIIb/IIIa抑制剂的患者中,在PCI后48小时内观察到事件减少了41% (4.9%与8.0%对比).
  • 在PCI后48小时内没有发现额外的益处或反弹效应.

结论:

  • 确的证据支持GP IIb/IIIa抑制剂在ACS患者中的早期益处.
  • 抑制GP IIb/IIIa可以防止与PCI相关的心肌损伤.
  • 这些发现证实了在治疗的两个阶段都有明显和显著的益处.